Point72 Asset Management’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-310,637
Closed -$913K 2547
2024
Q4
$913K Buy
+310,637
New +$1.27M ﹤0.01% 1485
2024
Q2
Sell
-1,612,542
Closed -$8.63M 2457
2024
Q1
$8.63M Buy
1,612,542
+1,262,702
+361% +$5.94M 0.02% 766
2023
Q4
$1.49M Sell
349,840
-1,310,160
-79% -$4.03M ﹤0.01% 1291
2023
Q3
$6.51M Buy
1,660,000
+383,048
+30% +$2.51M 0.02% 801
2023
Q2
$12.9M Buy
1,276,952
+1,065,673
+504% +$11.3M 0.04% 512
2023
Q1
$2.16M Sell
211,279
-70,371
-25% -$805K 0.01% 965
2022
Q4
$2.64M Buy
281,650
+123,200
+78% +$1.74M 0.01% 884
2022
Q3
$2.31M Sell
158,450
-79,850
-34% -$1.19M 0.01% 902
2022
Q2
$3.15M Sell
238,300
-72,400
-23% -$987K 0.01% 821
2022
Q1
$5.3M Sell
310,700
-276,007
-47% -$4.68M 0.02% 691
2021
Q4
$15M Buy
+586,707
New +$18.3M 0.06% 402

Other funds holding TSVT

Point72 Asset Management's TSVT Position: Q1 2025 in Review

Point72 Asset Management sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 310,637 shares — an estimated $913K sold.

Point72 Asset Management first reported a position in TSVT in Q4 2021 and held it in 11 quarters. The position peaked at $15M in Q4 2021. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Point72 Asset Management reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Point72 Asset Management sold 310,637 2seventy bio shares in Q1 2025, an estimated $913K.
  • Point72 Asset Management first reported a position in 2seventy bio in Q4 2021 and held it in 11 quarters.
  • Point72 Asset Management's 2seventy bio position peaked at $15M in Q4 2021.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.